Answer
The Praxbind (idarucizumab) product information states that effects on the ability to drive and use machines are “Not relevant.”
Sources for this answer
- Praxbind 2.5 g/50 mL solution for injection/infusionBoehringer Ingelheim Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 12Document updated
Sources checked